University of Nebraska Medical Center researchers have discovered a potential new therapeutic target for pancreatic cancer, detailed in a paper in a recent issue of the journal Gastroenterology.[?subhead]
The team established a new way to target pancreatic cancer cells by developing inhibitors that, when combined with existing chemotherapies, can diminish pancreatic cancer in mouse models. The discovery was a culmination of about seven years of work with collaborators from the Buck Institute for Research on Aging, Cold Spring Harbor Laboratory, Germany, India, China, Italy and Switzerland. Read more . . .